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Abstract
Background Aspirin exerts side effects within the gas-
trointestinal tract. Hydrogen sulfide (H2S) and carbon
monoxide (CO) have been implicated in gastroprotection
but the mechanism of beneficial action of these gaseous
mediators against aspirin-induced damage has not been
fully studied. We determined the involvement of afferent
sensory neurons, calcitonin-gene-related peptide (CGRP),
lipid peroxidation, and nitric oxide (NO) biosynthesis in
gastroprotection of H2S-releasing NaHS and CO-releasing
tricarbonyldichlororuthenium(II) dimer (CORM-2) against
aspirin-induced injury.
Methods Wistar rats with or without capsaicin-induced
denervation of sensory neurons were pretreated with
vehicle, CORM-2 (5 mg/kg intragastrically), or NaHS
(5 mg/kg intragastrically) with or without capsazepine
(5 mg/kg intragastrically) or NG-nitro-L-arginine (L-NNA,
20 mg/kg intraperitoneally). The areas of aspirin-induced
lesions and gastric blood flow (GBF) were assessed by
planimetry and laser flowmetry respectively. Gastric
mucosal messenger RNA and/or protein expression of
CGRP, heme oxygenase 1, inducible nitric oxide synthase,
cyclooxygenase 2, interleukin-1b, glutathione peroxi-
dase 1 (GPx-1), and superoxide dismutase was determined
by real-time PCR or Western blot. Malondialdehyde
(MDA) and 4-hydroxynonenal (4-HNE) content was
determined by colorimetric assay.
Results Aspirin caused gastric lesions, decreased GBF, and
raised MDA content, but pretreatment with NaHS and
CORM-2 reduced these effects. Capsaicin-induced dener-
vation or co-treatment with capsazepine reversed the gas-
troprotective and vasodilatory effects of NaHS but not
those of CORM-2. L-NNA reversed NaHS-induced gas-
troprotection and partly reduced CORM-2-induced gas-
troprotection. NaHS and CORM-2 decreased MDA and
4-HNE content, restoring GPx-1 protein expression.
Conclusions We conclude that H2S- but not CO-mediated
gastroprotection against aspirin-induced injury involves
afferent sensory nerves and partly NO activity. NaHS and
CORM-2 prevented aspirin-induced gastric mucosal lipid
peroxidation via restoration of microcirculation and
antioxidative GPx-1 protein expression.
Keywords Hydrogen sulfide  Carbon monoxide  Nitric
oxide  Afferent sensory nerves  Aspirin
Introduction
Aspirin is the most popular representative among the
nonsteroidal anti-inflammatory drugs (NSAIDs), which,
however, exerts side effects within the gastrointestinal
tract, including hemorrhagic microbleedings and gastric
erosions [1–4]. The gaseous mediators hydrogen sulfide
(H2S), carbon monoxide (CO), and nitric oxide (NO) were
reported to afford gastroprotection against injury induced
by noxious agents but the mechanism of this beneficial
action of these molecules has not been fully elucidated
[5–10]. All three mediators have been shown to take part in
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regulation of physiological processes in the gastrointestinal
tract and other systems [11–13].
The H2S-releasing derivatives of NSAIDs, such as
ATB-346, exert an anti-inflammatory effect similar to
that of the parent drugs (naproxen in the case of ATB-
346) but cause pronouncedly fewer side effects as
compared with the native form of the drug. This indi-
cates the usefulness of this new class of H2S derivatives
of NSAIDs and the potential safety and possible trans-
lation to clinical settings [14]. Moreover, these recently
introduced NSAID prodrugs—namely, H2S-releasing
anti-inflammatory drugs—were suggested as promising
agents in chemoprevention of cancers [15, 16]. Recently,
it has been reported that inhibition of H2S generation
contributes to the formation of aspirin-induced gastric
injury [5]. The CO and H2S biosynthesis pathways were
both shown to synergistically interact in the mechanism
of gastroprotection against NSAID-induced gastric
damage via restoration of gastric microcirculation
impaired by these drugs [17].
We aimed to investigate the involvement of afferent
sensory neurons, calcitonin-gene-related peptide (CGRP),
and vanilloid receptor 1 (also known as transient receptor
potential cation channel V1; TRPV1) in gastroprotection of
H2S released from NaHS and CO released from tricar-
bonyldichlororuthenium(II) dimer (CORM-2) and the
accompanying changes in gastric blood flow (GBF) with
regard to experimental gastric lesions induced by aspirin.
Moreover, we studied the potential role of H2S and CO in
regulation of aspirin-induced lipid peroxidation. We also
investigated the involvement of endogenous NO and
messenger RNA (mRNA) or protein expression of the
antioxidizing enzymes glutathione peroxidase 1 (GPx-1)
and superoxide dismutase (SOD) in the protective activity
of H2S and CO against aspirin-induced ulcerogenesis.
Materials and methods
Animals, chemicals and drugs, and determination
of the gastric damage and GBF
Seventy male Wistar rats weighting 220–300 g were fasted
for 24 h with free access to drinking water before the
experiments. The study was approved by the Institutional
Animal Care and Use Committee of Jagiellonian Univer-
sity Medical College in Cracow and was conducted in
accordance with the Helsinki Declaration regarding han-
dling of experimental animals.
Two weeks before the experiment, capsaicin was
administered subcutaneously to some of the rats (series A)
in three doses of 25, 50, and 50 mg/kg (total dose 125 mg/
kg) to induce the functional ablation of sensory nerves as
reported in our previous studies [18, 19].
On the day of experiment, aspirin dissolved in 0.2 M
HCl solution was administered intragastrically in a dose of
125 mg/kg (1.5 ml per rat) to induce gastric lesions, as
described previously [17]. Thirty minutes before aspirin
application, rats with capsaicin-induced denervation (series
A) and rats without capsaicin-induced denervation (series
B) were pretreated intragastrically with (1) 0.9% saline
(vehicle control) or dimethyl sulfoxide and saline (1:10),
(2) CO-releasing CORM-2 [20], applied in a dose of 5 mg/
kg, which has previously been reported by our group to
increase CO content in gastric mucosa and to exert gas-
troprotection against aspirin- and ethanol-induced gastric
damage [17, 21], or (3) NaHS, the H2S-releasing salt
applied intragastrically in a dose of 5 mg/kg, which has
been demonstrated to protect gastric mucosa against
aspirin-, stress-, or alendronate-induced lesions
[17, 19, 22]. In a separate series (C), rats with intact sen-
sory nerves were pretreated with NaHS or CORM-2 in
combination with capsazepine (5 mg/kg intragastrically), a
TRPV1 antagonist [23], or NG-nitro-L-arginine (L-NNA,
20 mg/kg intraperitoneally), a nonselective nitric oxide
synthase (NOS) inhibitor [24]. All chemicals were pur-
chased from Sigma-Aldrich (Schnelldorf, Germany) and
were injected intraperitoneally or administered intragas-
trically by means of an orogastric tube as reported previ-
ously [18, 25].
One hour after administration of aspirin, rats were
anesthetized with pentobarbital (60 mg/kg intraperi-
toneally). Their abdomens were opened for the GBF
measurement by a laser Doppler flowmeter (Laserflo blood
perfusion monitor, model BPM 403A, Vasamedics, St
Paul, MN, USA), as described elsewhere [25]. The stomach
was excised and opened along the greater curvature to
determine the area of aspirin-induced gastric lesions by
means of computerized planimetry (Morphomat, Carl
Zeiss, Berlin, Germany) [26, 27]. Next, the gastric mucosal
samples from oxyntic mucosa were scraped off on ice,
snap-frozen in liquid nitrogen, and stored at -80 C until
further analysis [21].
Determination of mRNA expression of b-actin, a-
CGRP, heme oxygenase 1, cyclooxygenase 2,
inducible NOS, interleukin-1b, GPx-1, and SOD-2
in rat gastric mucosa by real-time polymerase chain
reaction
Expression of mRNA for particular genes of interest in
gastric mucosa was determined by real-time polymerase
chain reaction (PCR) as described previously [21, 22].
Briefly, RNA was isolated from gastric mucosal biopsy
samples with use of a GeneMATRIX universal RNA
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purification kit (EURx, Gdansk, Poland). Reverse tran-
scription to complementary DNA was performed with a
high-capacity complementary DNA reverse transcription
kit (Thermo Fisher Scientific, Life Technologies, MA,
USA). Expression of b-actin, heme oxygenase 1 (HO-1),
cyclooxygenase (COX)-2, inducible NOS (iNOS), inter-
leukin-1b (IL-1b), GPx-1, and SOD-2 was determined by
real-time PCR using specific primers [17, 22], SG qPCR
master mix (29) including SYBR Green (EURx, Gdansk,
Poland), and Quant Studio 12K Flex thermal cycler
(Thermo Fisher Scientific, MA, USA). To determine a-
CGRP mRNA expression, 50-GCTCACCAGGGAGG-
CATCAT-30 forward primer and 50-ATGCCTGGTA-
CAGGAGCAAGA-30 reverse primer were used. b-Actin
was used as an internal control. Data were analyzed by the
2DCt method [28].
Determination of protein expression in gastric
mucosa by Western blot
Protein expression of b-actin, GPx-1, SOD-1, and iNOS in
gastric mucosa was determined by Western blot, as
described previously [17, 21, 22]. Rabbit polyclonal anti-
iNOS antibody (1:500, ab3523, Abcam, Cambridge, UK),
rabbit polyclonal anti-GPx-1 antibody (1:1000, ab22604,
Abcam), rabbit polyclonal anti-SOD-1 antibody (1:1000,
ab13498, Abcam), and rabbit polyclonal anti-b-actin anit-
body (1:1000, 20536-1-AP, Proteintech, Manchester, UK)
were used as primary antibodies. Protein expression was
visualized by means of peroxidase-conjugated secondary
goat anti-rabbit IgG antibody (sc-2004, Santa Cruz
Biotechnology) at a dilution of 1:2000. All primary and
secondary antibodies were diluted in 5% nonfat milk.
Chemiluminescence was developed with use of
WesternSure enhanced chemiluminescence substrate (LI-
COR, Lincoln, NE, USA) and was measured with a
C-DiGit blot scanner (LI-COR). The intensity of bands
was determined and analyzed by Image Studio 4.0 (LI-
COR). The expression of the proteins of interest was nor-
malized to the expression of b-actin as a loading control.
Determination of the gastric mucosal lipid
peroxidation as malondialdehyde and 4-
hydroxynonenal content
To determine malondialdehyde (MDA) and 4-hydrox-
ynonenal (4-HNE) tissue concentration, the colorimetric
assay for lipid peroxidation (Bioxytech LPO-586, Oxis,
Portland, OR, USA) was used as described previously [27].
In brief, about 200 mg of gastric mucosa was excised and
then quickly washed in a test tube, and 20 lL 0.5 M buty-
lated hydroxytoluene was added to prevent sample oxida-
tion. Next, samples were homogenized in 20 mM
tris(hydroxymethyl)aminomethane for 15 s in pH 7.4 and
centrifuged (3000g at 4 C for 10 min). The supernatant was
collected and stored at -80 C until further analysis. The
colorimetric assay used to determine MDA concentration in
gastric mucosa is based on the reaction of a chromogenic
reagent (N-methyl-2-phenylindole) with MDA and 4-HNE
at 45 C, which yields a stable chromophore with maximal
absorbance at 586 nm, analyzed with a microplate reader
(Tecan Sunrise, Männedorf, Switzerland).
Statistical analysis
The results are presented as the mean ± standard error of
the mean. Statistical analysis was performed with Student’s
t test or the Mann–Whitney U test if appropriate assump-
tions did not hold. ANOVA with the Tukey post hoc test
was used if more than two experimental groups were
compared. We considered p\ 0.05 to be statistically sig-
nificant. Data were analyzed with GraphPad Prism 5.0.
Results
Effect of afferent sensory nerve ablation
and inhibition of TRPV1 receptors on CORM-2-
and NaHS-mediated gastroprotection
Figure 1 shows that pretreatment with CORM-2 (5 mg/kg
intragastrically) and NaHS (5 mg/kg intragastrically) sig-
nificantly decreased the mean area of gastric lesions and
significantly increased GBF as compared with vehicle
pretreatment (p\ 0.05) (Fig. 1). These data confirm our
previously published results that CO and H2S donors pro-
tected gastric mucosa against aspirin-induced gastric
damage [17]. Capsaicin-induced denervation significantly
increased the area of aspirin-induced gastric lesions and
decreased GBF as compared with vehicle treatment in rats
with intact sensory nerves (p\ 0.05) (Fig. 1). The reduc-
tion of the area of gastric lesions and the accompanying
increase in GBF caused by NaHS were reversed in rats
with capsaicin-induced denervation (p\ 0.05) (Fig. 1).
Capsazepine (5 mg/kg intragastrically) by itself did not
affect aspirin-induced gastric damage and GBF as com-
pared with vehicle treatment (Fig. 1). When NaHS was
combined with capsazepine, a significant increase in the
mean area of gastric lesions as compared with that for rats
pretreated with this H2S donor alone was observed
(p\ 0.05), whereas GBF was significantly increased as
compared with that in the vehicle-control group (p\ 0.05).
The capsazepine and CORM-2 co-treatment failed to affect
the decrease of gastric damage area and the increase in
GBF as compared with the respective values obtained in
the group of rats pretreated with CORM-2 alone (Fig. 1).
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Expression of CGRP mRNA in gastric mucosa
Figure 2 shows that the CGRP mRNA expression in gastric
mucosa with aspirin-induced gastric damage was signifi-
cantly increased in rats with capsaicin-induced denervation
pretreated with vehicle as compared with the respective
values in intact gastric mucosa and the vehicle-pretreated
group without sensory denervation (p\ 0.05) (Fig. 2).
Pretreatment with CORM-2 but not with NaHS signifi-
cantly decreased mRNA expression of CGRP in gastric
mucosa of rats with capsaicin-induced functional ablation
of afferent sensory neurons in which aspirin was admin-
sitered as compared with the vehicle-control group
(p\ 0.05) (Fig. 2).
Expression of HO-1, iNOS, COX-2, and IL-1b
mRNA in gastric mucosa
Figure 3 shows that the mRNA expression for HO-1,
iNOS, COX-2, or IL-1b was significantly increased in
vehicle-pretreated gastric mucosa in rats administered with
aspirin as compared with that observed in intact rats
(p\ 0.05). Pretreatment with CORM-2 significantly
increased mRNA expression of HO-1 and significantly
decreased mRNA expression of iNOS, COX-2, and IL-1b
in rats with aspirin-induced gastric damage as compared
with the vehicle-control group without capsaicin-induced
Fig. 1 a Mean lesion area and b gastric blood flow (GBF) in gastric
mucosa of rats with or without afferent sensory nerves denervation
and pretreated with vehicle, NaHS (5 mg/kg intragastrically), or
tricarbonyldichlororuthenium(II) dimer (CORM-2; 5 mg/kg intragas-
trically) alone or in combination with capsazepine (5 mg/kg intra-
gastrically) and administered with aspirin (ASA; 125 mg/kg
intragastrically). The results are mean ± standard error of the mean
for four or five rats per experimental group. A significant change as
compared with the respective values in the vehicle-control group with
intact sensory nerves is indicated by one asterisk (p\ 0.05). One
cross indicates a significant change as compared with the respective
values in rats with intact sensory neurons and pretreated with NaHS
alone (p\ 0.05). A significant change as compared with the
respective values in the capsaicin-denervated vehicle-control group
is indicated by two crosses (p\ 0.05). A significant change as
compared with the respective values in the vehicle-control group
treated with capsazepine alone is indicated by two asterisks
(p\ 0.05). i.g. intragastrically
Fig. 2 Calcitonin-gene-related peptide (CGRP) messenger RNA
(mRNA) expression in gastric mucosa of rats with or without
capsaicin-induced denervation and pretreated with vehicle, NaHS
(5 mg/kg intragastrically), or tricarbonyldichlororuthenium(II) dimer
(CORM-2; 5 mg/kg intragastrically) and administered with aspirin
(ASA; 125 mg/kg intragastrically). Intact refers to healthy rats without
any treatment. The results are expressed as CGRP mRNA expression
normalized to b-actin expression and are the mean ± standard error
of the mean for four or five rats per group. An asterisk indicates a
significant change as compared with the values in the vehicle-control
group without capsaicin-induced denervation (p\ 0.05). A cross
indicates a significant change as compared with the values obtained in
the vehicle-pretreated group with capsaicin-induced denervation
(p\ 0.05). i.g. intragastrically
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denervation (p\ 0.05) (Fig. 3). The pretreatment with
NaHS significantly decreased mRNA expression of IL-1b
but not that of HO-1, iNOS, or COX-2 as compared with
vehicle treatment without capsaicin-induced denervation
(p\ 0.05) (Fig. 3). These results confirmed our data pub-
lished previously [17]. In vehicle-pretreated rats with
capsaicin-induced denervation, mRNA expression of HO-
1, iNOS, or IL-1b was significantly increased as compared
with that in respective group without capsaicin denervation
(p\ 0.05) (Fig. 3a, b, d). In rats with afferent sensory
nerves ablation, pretreatment with CORM-2 but not NaHS
significantly decreased IL-1b mRNA expression as com-
pared with that in the vehicle-treated control group
(p\ 0.05) (Fig. 3d). Pretreatment with CORM-2 or NaHS
Fig. 3 Messenger RNA (mRNA) expression of a heme oxygenase 1
(HO-1), b inducible nitric oxide synthase (iNOS), c cyclooxygenase 2
(COX-2), and d interleukin-1b (IL-1b) in gastric mucosa of rats with
or without capsaicin-induced denervation and pretreated with vehicle,
NaHS (5 mg/kg intragastrically), or tricarbonyldichlororuthenium(II)
dimer (CORM-2; 5 mg/kg intragastrically) and 30 min later given
aspirin (ASA; 125 mg/kg intragastrically). Intact refers to healthy rats
without any treatment. The results are expressed as mRNA expression
of HO-1 (a), iNOS (b), COX-2 (c), and IL-1b (d) normalized to b-
actin expression and are the mean ± standard error of the mean of
four or five determinations per group. One asterisk indicates a
significant change as compared with the values in intact gastric
mucosa (p\ 0.05). A significant change as compared with the values
obtained in the vehicle-pretreated group with intact sensory nerves is
indicated by a cross or two asterisks (p\ 0.05). A significant change
as compared with the vehicle-control group with capsaicin-induced
denervation is indicated by two crosses (p\ 0.05). i.g.
intragastrically
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did not affect mRNA expression of HO-1, iNOS, or COX-2
in gastric mucosa of rats with sensory nerve ablation and
given aspirin.
Expression of GPx-1 and SOD-2 mRNA in gastric
mucosa
The results for gastric mucosal mRNA expression of GPx-1
and SOD-2 in intact rats and those with or without cap-
saicin-induced denervation pretreated with vehicle,
CORM-2, or NaHS and exposed to aspirin are presented in
Fig. 4. The expression of GPx-1 and SOD-2 mRNA was
significantly decreased in vehicle-pretreated rats given
aspirin as compared with intact rats (p\ 0.05). Pretreat-
ment with NaHS significantly increased GPx-1 and SOD-2
mRNA expression in gastric mucosa of rats with intact
sensory nerves (p\ 0.05) (Fig. 4). In rats with intact
sensory nerves, the pretreatment with NaHS failed to affect
GPx-1 or SOD-2 mRNA expression as compared with
vehicle pretreatment combined with exposure to aspirin
(Fig. 4). Likewise, in rats with capsaicin-induced dener-
vation, the pretreatment with NaHS did not affect GPx-1 or
SOD-2 mRNA expression as compared with vehicle pre-
treatment combined with exposure to aspirin but this
mRNA expression for both antioxidizing enzymes was
significantly decreased as compared with that in the group
with intact sensory nerves and pretreated with NaHS
(p\ 0.05) (Fig. 4).
Effect of NOS inhibition on CORM-2- and NaHS-
mediated gastroprotection against aspirin-induced
gastric damage
Figure 5 shows that CORM-2 and NaHS administered in a
dose of 5 mg/kg intragastrically significantly decreased the
area of aspirin-induced gastric damage (Fig. 5a) and
increased GBF (Fig. 5b) as compared with vehicle treatment
(p\ 0.05), and these results are similar to the data presented
in Fig. 1. When CORM-2 was administered with L-NNA, the
area of gastric lesions was significantly increased as com-
pared with that in vehicle-pretreated rats receiving CORM-2
and compromised by aspirin (control) (p\ 0.05) but the
GBF was not significantly altered in these rats (Fig. 5).
Concurrent administration of NaHS and L-NNA (20 mg/kg
intraperitoneally) significantly increased the area of gastric
lesions (Fig. 5a) and significantly decreased GBF (Fig. 5b)
as compared with the values observed when this H2S donor
was applied without L-NNA (p\ 0.05).
Fig. 4 Messenger RNA (mRNA) expression of a glutathione perox-
idase 1 (GPx-1) and b) superoxide dismutase 2 (SOD-2) in gastric
mucosa of rats with or without capsaicin-induced denervation and
pretreated with vehicle, NaHS (5 mg/kg intragastrically), or tricar-
bonyldichlororuthenium(II) dimer (CORM-2; 5 mg/kg intragastri-
cally) and administered with aspirin (ASA; 125 mg/kg
intragastrically). Intact refers to healthy rats without any treatment.
The results are expressed as mRNA expression of GPx-1 (a) and
SOD-2 (b) normalized to b-actin expression and are the
mean ± standard error of the mean of four or five determinations
per group. One asterisk indicates a significant change as compared
with the values in intact gastric mucosa (p\ 0.05). A cross indicates
a significant change as compared with the values obtained in the
vehicle-pretreated group with intact sensory nerves (p\ 0.05). A
significant change as compared with the values obtained in NaHS-
pretreated rats with intact sensory nerves is indicated by two asterisks
(p\ 0.05). i.g. intragastrically
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Protein expression of iNOS, SOD-1 and GPx-1
in gastric mucosa
Figure 6a shows that protein expression of iNOS is sig-
nificantly increased in gastric mucosa compromised by
aspirin as compared with that in intact rats (p\ 0.05).
Pretreatment with CORM-2 (5 mg/kg intragastrically) but
not with NaHS (5 mg/kg intragastrically) significantly
decreased iNOS protein expression as compared with that
in the vehicle-control group (p\ 0.05) (Fig. 6a). Figure 6b
and c shows that protein expression of SOD and GPx-1 was
significantly decreased in gastric mucosa in rats given
aspirin as compared with intact gastric mucosa (p\ 0.05).
Pretreatment with CORM-2 (5 mg/kg intragastrically) or
NaHS (5 mg/kg intragastrically) significantly increased
protein expression of GPx-1 but not SOD-1 as compared
with vehicle pretreatment (p\ 0.05) (Fig. 6b, c).
Determination of MDA and 4-HNE content
in gastric mucosa
MDA and 4-HNE content in gastric mucosa was signifi-
cantly increased in rats pretreated with vehicle and given
aspirin as compared with intact rats (p\ 0.05) (Fig. 7).
The pretreatment with CORM-2 (5 mg/kg intragastrically)
or NaHS (5 mg/kg intragastrically) significantly decreased
MDA and 4-HNE content in gastric mucosa compromised
by aspirin as compared with vehicle pretreatment
(p\ 0.05).
Discussion
In this study we used an experimental model of acute
aspirin-induced gastric damage, which resembles microb-
leedings and gastric erosions in human gastric mucosa.
Previous studies have documented that the mechanism of
aspirin-induced gastric damage involves an inhibition of
cytoprotective prostaglandin E2 production via COX-1/
COX-2 enzymatic activity and the prominent fall in GBF
leading to the formation of severe hemorrhagic lesions of
gastric mucosa [5, 29–33]. On the other hand, recent
studies reported that the endogenous gaseous mediators
H2S, CO, and NO contribute to the maintenance of gastric
mucosal integrity and prevent the formation of gastric
mucosal lesions induced by various noxious stimuli, such
as exposure to stress or administration of ethanol, bispho-
sphonates, and NSAIDs, including aspirin
[5, 17, 19, 21, 22, 26, 34].
We have observed that pretreatment with CORM-2 or
NaHS, both applied in a dose of 5 mg/kg, protected gastric
mucosa against aspirin-induced gastric damage and
increased the GBF, which is similar to what our group
presented elsewhere [17]. Herein, we have demonstrated
for the first time that this beneficial protective effect of an
H2S donor but not that of a CO donor was reduced in rats
with capsaicin-induced denervation, suggesting that the
protective activity of NaHS releasing H2S unlike CORM-2
releasing CO can be mediated by neuropeptides such as
CGRP released from sensory afferent nerves. Moreover,
we found that neither NaHS nor CORM-2 had any signif-
icant influence on the gastric mucosal expression of CGRP
in rats without sensory innervation treated with aspirin.
However, this expression of CGRP was dramatically
upregulated in rats with capsaicin-induced afferent sensory
Fig. 5 a Mean lesion area and b gastric blood flow (GBF) in gastric
mucosa of rats pretreated with vehicle, NaHS (5 mg/kg intragastri-
cally), or tricarbonyldichlororuthenium(II) dimer (CORM-2; 5 mg/kg
intragastrically) alone or in combination with NG-nitro-L-arginine (L-
NNA; 20 mg/kg intraperitoneally) and given aspirin (ASA; 125 mg/kg
intragastrically). The results are the mean ± standard error of the
mean for four or five rats per experimental group. A significant
change as compared with the respective values in the vehicle-control
group is indicated by one asterisk (p\ 0.05). A cross indicates a
significant change as compared with the respective values in the
NaHS-treated group (p\ 0.05). A significant change as compared
with the respective values in the group pretreated with CORM-2
alone is indicated by two asterisks (p\ 0.05). i.g. intragastrically, i.p.
intraperitoneally
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Fig. 6 Protein expression of a inducible nitric oxide synthase iNOS),
b superoxide dismutase 1 (SOD), and c glutathione peroxidase 1
(GPx) in gastric mucosa of rats pretreated with vehicle, NaHS (5 mg/
kg intragastrically) or tricarbonyldichlororuthenium(II) dimer
(CORM-2; 5 mg/kg intragastrically) and 30 min later given aspirin
(ASA; 125 mg/kg intragastrically). Intact refers to healthy rats without
any treatment. The results are expressed as protein expression of
iNOS, SOD, or GPx normalized to b-actin expression and are the
mean ± standard error of the mean for four or five rats per group. An
asterisk indicates a significant change as compared with the values in
intact gastric mucosa (p\ 0.05). A cross indicates a significant
change as compared with the values obtained in the vehicle-pretreated
group (p\ 0.05). i.g. intragastrically
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nerve denervation, and this effect was attenuated by pre-
treatment with CORM-2 but not NaHS.
We studied whether the protection by H2S against
aspirin ulcerogenesis could be mediated by the NO–
TRPV1–CGRP signaling pathway. Recently, the H2S-
evoked vasodilatory effects were attributed to NO pro-
duction and activation of the HNO–transient receptor
potential cation channel A1 (TRPA1)–CGRP pathway,
indicating that these mediators can contribute to the
enhancement in the gastric microcirculation observed in
the present study [35]. When an H2S donor was adminis-
tered in combination with the TRPV1 antagonist cap-
sazepine, the NaHS-induced protection was reversed.
However, capsazepine did not affect the NaHS-induced
increase in GBF, suggesting that in this model H2S can
regulate GBF with no involvement of TRPV1 receptors.
On the other hand, capsazepine failed to influence the
CORM-2-induced attenuation of aspirin damage and the
accompanying rise in GBF. We observed that capsaicin-
induced denervation even further enhanced the increase of
mRNA expression of proinflammatory markers such as
iNOS, IL-1b, COX-2, and HO-1 observed in rats subjected
to aspirin. The expression of proinflammatory IL-1b
mRNA was abrogated by CORM-2, and this effect was not
influenced by capsaicin-induced denervation in contrast
to groups pretreated with NaHS. However, neither a CO
donor nor H2S-releasing NaHS, decreased upregulated
mRNA expression of HO-1, iNOS, or COX-2 in rats with
sensory nerve ablation. On the basis of these findings, we
assume that CO decreased infiltration of IL-1b-induced
activation of neutrophils and macrophages in the gastric
mucosa after administration of aspirin in rats with cap-
saicin-induced denervation. However, this gaseous media-
tor was not sufficiently effective in regulation of
intracellular inflammation because it failed to affect an
increase in iNOS, HO-1, and COX-2 mRNA expression in
these rats with capsaicin-induced denervation. In contrast
to rats with intact sensory nerves, the pretreatment with
NaHS did not alter the mRNA expression of the antiox-
idative enzymes GPx-1 or SOD-2 in gastric mucosa com-
promised by aspirin, which was evidently suppressed in
rats with capsaicin-induced denervation, confirming that
H2S-donor-mediated gastroprotection depends on afferent
sensory nerve activity. The results of the present study
corroborate with previously published evidence that
NaHS-induced gastroprotection against stress-induced
gastric mucosal lesions is attenuated in rats with functional
ablation of afferent sensory nerves [19]. Therefore, we
conclude that the gastroprotective effect of NaHS releasing
H2S against aspirin-induced lesions depends on the activity
of afferent sensory neurons and CGRP, which is known to
exert vasodilatory, anti-inflammatory, and antioxidative
properties. However, sensory nerves releasing vasodilatory
neuropeptides seem to be less important in CORM-2-in-
duced gastroprotection because despite this CO donor
reduced aspirin-induced damage, it failed to attenuate all
molecular proinflammatory and antioxidative parameters
overexpressed in rats with capsaicin-induced denervation.
Our data suggest that H2S-induced gastroprotection
against aspirin-induced damage may involve endogenous
NO biosynthesis since administration of a nonselective NO
inhibitor, L-NNA, completely abolished the protective and
hyperemic effects of NaHS in rats administered with
aspirin. CO-mediated gastroprotection was only reduced
when CORM-2 was combined with L-NNA. Moreover, the
upregulation of gastric mucosal iNOS protein expression
induced by aspirin was decreased in rats pretreated with
CORM-2 but not with NaHS. This finding is in keeping
with our previous observation that CO released from
CORM-2 decreased NO content that was possibly elevated
because of an increase in iNOS activity in gastric mucosa
of rats compromised by stress and that L-NNA had no
effect on the gastroprotective action of this compound [26].
Regarding the effect of L-NNA on NaHS-induced gastro-
protection, there is convincing evidence that H2S can
interact with NO in the regulation of mucus secretion,
GBF, and gastric mucosal defense in experimental models
Fig. 7 Malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE)
content in gastric mucosa of rats pretreated with vehicle, NaHS
(5 mg/kg intragastrically), or tricarbonyldichlororuthenium(II) dimer
(CORM-2; 5 mg/kg intragastrically) and given aspirin (ASA; 125 mg/
kg intragastrically). Intact refers to healthy rats without any treatment.
The results are the mean ± standard error of the mean for four or five
rats per group. An asterisk indicates a significant change as compared
with the values in intact gastric mucosa (p\ 0.05). A cross indicates
a significant change as compared with the values obtained in the
vehicle-pretreated group (p\ 0.05). i.g. intragastrically
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and in regulation of vascular tone in animals and humans
[36, 37]. We cannot exclude the possibility that NO is
involved in CORM-2-induced gastroprotection because an
in vitro study revealed that CORM-2 directly enhanced
endothelial NOS activity mediated by intracellular calcium
release, intracellular Akt signaling, and endothelial NOS
dimerization [38]. Therefore, we conclude that endogenous
NO can mediate H2S gastroprotection against aspirin-in-
duced gastric damage and that this endogenous mediator
can be, only in part, involved in CO-induced
gastroprotection.
After administration of aspirin, lipid peroxidation was
increased since the MDA and 4-HNE content in gastric
mucosa reached higher concentrations than those recorded
in healthy intact rats, whereas the protein expression and
mRNA expression in gastric mucosa for the antioxidative
enzymes GPx-1 and SOD were both decreased in aspirin-
treated gastric mucosa. CORM-2 and NaHS prevented an
aspirin-induced increase in gastric mucosal lipid peroxi-
dation and restored protein expression of GPx-1 but not
that of SOD-1. This effect could be explained by an
aspirin-induced decrease in gastric mucosa of the avail-
ability of metals, which are known to be bound to SOD
[39, 40]. Both CORM-2 and NaHS failed to reduce this
effect of aspirin, because SOD protein expression remained
decreased as observed 1 h after aspirin administration. We
speculate that a longer time after aspirin administration
than that used in our study is needed to observe the influ-
ence of NaHS and CORM-2 on aspirin-induced impairment
in SOD protein expression. However, in contrast to
CORM-2, pretreatment with NaHS increased mRNA
expression for antioxidative SOD-2 in gastric mucosa
compromised by aspirin. NaHS but not CORM-2 restored
GPx-1 mRNA expression in gastric mucosa injured by
aspirin. Together these observations suggest that mainly
H2S but to lesser degree of CO can promote an antiox-
idative response in gastric mucosa at the mRNA level for
both enzymes. It has previously been reported that differ-
ences in GPx-1 and SOD activities could serve as a marker
of the pathological condition [41]. Our present observa-
tions support recent findings that H2S-releasing Lawes-
son’s reagent or another CO donor, dimanganese
decacarbonyl, protected gastric mucosa against alen-
dronate-induced gastric damage via regulation of oxidative
stress as manifested by an increase in reduced glutathione
content and a decrease in MDA content in rat gastric
mucosa injured by alendronate [42, 43]. Thus, we conclude
that the antioxidative properties of the gaseous mediators
CO and H2S can contribute, at least in part, to the observed
gastroprotective effect of these molecules against aspirin-
induced gastric damage. CO seems to protect gastric
mucosa against oxidation induced by aspirin, whereas
additionally H2S stimulates an antioxidative gastric
mucosal response at the molecular level.
From the findings taken together, we conclude that
H2S-mediated gastroprotection against aspirin-induced
mucosal lesions involves an increase in gastric microcir-
culation mediated by endogenous NO. However, a CO-
mediated beneficial protective effect against aspirin-in-
duced damage may depend only in part on NO biosyn-
thesis. NaHS-induced gastroprotection unlike CORM-2-
induced gastroprotection depends on the activity of
afferent sensory nerves releasing CGRP and on the acti-
vation of TRPV1. Both H2S released from NaHS and CO
released from CORM-2 attenuate the aspirin-induced rise
in MDA content considered as an index of gastric
mucosal lipid peroxidation and can improve the antiox-
idative status of gastric mucosa because of the restoration
of antioxidative GPx-1 protein expression impaired by
aspirin treatment.
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